Search Results

There are 11922 results for: content related to: A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients


    Journal of the American Geriatrics Society

    Volume 16, Issue 8, August 1968, Pages: 874–886, János P. Radó, Judit Marosi, László Szende and József Takó

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1968.tb02682.x

  2. Spironolactone for hypertension

    Intervention Review

    The Cochrane Library

    Josh Batterink, Sarah N Stabler, Aaron M Tejani and Curt T Fowkes

    Published Online : 4 AUG 2010, DOI: 10.1002/14651858.CD008169.pub2

  3. The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception

    European Journal of Pain

    Volume 18, Issue 3, March 2014, Pages: 386–395, T.O. Lilius, V. Jokinen, M.S. Neuvonen, A.J. Väänänen, M. Niemi, P.V. Rauhala and E.A. Kalso

    Version of Record online : 30 JUL 2013, DOI: 10.1002/j.1532-2149.2013.00371.x

  4. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne

    Intervention Review

    The Cochrane Library

    Julie Brown, Cindy Farquhar, Olivia Lee, Robyn Toomath and Ruth G Jepson

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD000194.pub2

  5. You have free access to this content
    Interventions for hirsutism (excluding laser and photoepilation therapy alone)

    Intervention Review

    The Cochrane Library

    Esther J van Zuuren, Zbys Fedorowicz, Ben Carter and Nikolaos Pandis

    Published Online : 28 APR 2015, DOI: 10.1002/14651858.CD010334.pub2

  6. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patents

    Clinical Pharmacology & Therapeutics

    Volume 27, Issue 4, April 1980, Pages: 533–543, L E Ramsay, J Hettiarachchi, R Fraser and J J Morton

    Version of Record online : 16 APR 1980, DOI: 10.1038/clpt.1980.75

  7. You have free access to this content
    Aldosterone antagonists for preventing the progression of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Davide Bolignano, Suetonia C Palmer, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 29 APR 2014, DOI: 10.1002/14651858.CD007004.pub3

  8. Management of resistant hypertension: Aldosterone antagonists or intensification of diuretic therapy?


    Volume 20, Issue 8, August 2015, Pages: 567–571, Ursula Verdalles, Soledad García de Vinuesa, Marian Goicoechea, Nicolas Macías, Alba Santos, Ana Perez de Jose, Eduardo Verde, Claudia Yuste and Jose Luño

    Version of Record online : 21 JUL 2015, DOI: 10.1111/nep.12475

  9. You have full text access to this Open Access content
    Myocardial changes after spironolactone in spontaneous hypertensive rats. A laser scanning confocal microscopy study

    Journal of Cellular and Molecular Medicine

    Volume 6, Issue 1, January 2002, Pages: 49–57, Leila Maria Meirelles Pereira and C.A. Mandarim-de-Lacerda

    Version of Record online : 1 MAY 2007, DOI: 10.1111/j.1582-4934.2002.tb00310.x

  10. You have free access to this content
    Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia.

    British Journal of Clinical Pharmacology

    Volume 14, Issue 2, August 1982, Pages: 257–263, PR Jackson, LE Ramsay and V Wakefield

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1982.tb01970.x

  11. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease

    Intervention Review

    The Cochrane Library

    Audra Stewart, Luc P Brion and Iris Ambrosio-Perez

    Published Online : 7 SEP 2011, DOI: 10.1002/14651858.CD001817.pub2

  12. You have free access to this content
    Spironolactone Use in Heart Failure Patients With End-Stage Renal Disease on Hemodialysis: Is It Safe?

    Clinical Cardiology

    Volume 33, Issue 10, October 2010, Pages: 604–608, Doson Chua, Anita Lo and Chris Lo

    Version of Record online : 19 OCT 2010, DOI: 10.1002/clc.20838

  13. Comparison of electrospun and extruded soluplus®-based solid dosage forms of improved dissolution

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 1, January 2012, Pages: 322–332, Zsombor K. Nagy, Attila Balogh, Balázs Vajna, Attila Farkas, Gergő Patyi, Áron Kramarics and György Marosi

    Version of Record online : 23 AUG 2011, DOI: 10.1002/jps.22731

  14. Medical Treatment of Ascites in Cirrhosis

    Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment, Second Edition

    Paolo Angeli, Angelo Gatta, Pages: 227–240, 2007

    Published Online : 25 OCT 2007, DOI: 10.1002/9780470987476.ch18

  15. You have free access to this content
    Protective effects of spironolactone against anthracycline-induced cardiomyopathy

    European Journal of Heart Failure

    Volume 17, Issue 1, January 2015, Pages: 81–89, Mahmut Akpek, Ibrahim Ozdogru, Omer Sahin, Mevlude Inanc, Ali Dogan, Cevat Yazici, Veli Berk, Halit Karaca, Nihat Kalay, Abdurrahman Oguzhan and Ali Ergin

    Version of Record online : 20 NOV 2014, DOI: 10.1002/ejhf.196

  16. Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study

    Diabetic Medicine

    Volume 29, Issue 8, August 2012, Pages: e184–e190, S. E. Nielsen, F. Persson, E. Frandsen, T. Sugaya, G. Hess, D. Zdunek, K. J. Shjoedt, H-H. Parving and P. Rossing

    Version of Record online : 15 JUL 2012, DOI: 10.1111/j.1464-5491.2012.03585.x

  17. Hepatorenal syndrome and ascites - questions and answers


    Volume 19, Issue s1, December 1999, Pages: 15–74, M. Bernardi, L. Blendis, A. K. Burroughs, G. Laffi, J. Rodes and P. Gentilini

    Version of Record online : 2 MAR 2007, DOI: 10.1111/j.1478-3231.1999.tb00092.x

  18. Pathogenesis, Diagnosis and Treatment of Ascites in Cirrhosis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Vicente Arroyo, Carlos Terra, Luis Ruiz-del-Arbol, Pages: 666–710, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch7e

  19. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome

    Clinical Pharmacology & Therapeutics

    Volume 21, Issue 2, February 1977, Pages: 234–243, Gordon R. Lang, Christof Westenfelder, Luiz Nascimento, Virendra B. Dhupelia, Jose A. L. Arruda and Robert E. Kane

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1977212234

  20. You have free access to this content
    Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial

    European Journal of Heart Failure

    Volume 10, Issue 2, February 2008, Pages: 157–163, R.A.P. Weir, John J.V. McMurray, Margareta Puu, Scott D. Solomon, Bertil Olofsson, Christopher B. Granger, Salim Yusuf, Eric L. Michelson, Karl Swedberg, Marc A. Pfeffer and CHARM Investigators

    Version of Record online : 13 JAN 2014, DOI: 10.1016/j.ejheart.2007.12.006